Newly reprogrammed metabolic pathways and oncometabolites influence the tumorigenic environment. The development of ways to modulate metabolic reprogramming in pancreatic cancer cells could pave the way for a novel treatment strategy. The primary metabolic pathways that provide acetyl-CoA and NADPH, which are required for lipid synthesis and cell proliferation in pancreatic cancer cells.
